Recent studies have identified the MD-2/TLR4/NF-κB axis as a key mechanism in HFD- and obesity-related renal damage, suggesting that targeting this pathway may provide a novel approach to mitigating HFD-induced nephropathy [8,30,31,32,33]. Here, LY96 is linked to kidney disorder.